David Cavalla, PhD Chief Executive Officer Arachnova Ltd. Cambridge, England, UK     Ulrich Elben, PhD Project Director Project Management and Productivity Drug Innovation & Approval Hoechst Marion Roussel Deutschland GmbH Frankfurt, Germany     R.J. Fenton, BSc, PhD Group Leader Systems Biology Unit Glaxo Wellcome Research & Development Stevenage, England, UK     Irene François, PhD Director of Research and Development Rademacher Group Ltd. Oxford, England, UK     Simon T. Hodgson, PhD Group Leader, Combinatorial Medicinal Chemistry Research Project Leader, UK Discovery Glaxo Wellcome Stevenage, England, UK     Patrick P. A. Humphrey, OBE, DSc, PhD Director Glaxo Institute of Applied Pharmacology Department of Pharmacology University of Cambridge Cambridge, England, UK     Timothy J. Maziasz, PhD Director COX-2 Technology Searle Research & Development G.D. Searle & Co. Skokie, Illinois, USA     James E. Niedel, MD, PhD, FRCP Executive Director Science and Technology Glaxo Wellcome plc Middlesex, England, UK     Thomas F. Schaible, PhD Senior Director Immunology Medical Affairs Centocor Malvern, Pennsylvania, USA     David E. Tupper, PhD, MRSC, CChem Research Leader Lilly Research Centre Ltd. Eli Lilly and Co. Surrey, England, UK         [ Welcome ] [ Webcast ] [ Faculty ] [ About SMR ] [ Technical Instructions ]   Webcast produced by Prous Science © 2000 Prous Science. All rights reserved